×
Kamada Income Taxes 2012-2024 | KMDA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Kamada income taxes from 2012 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
View More
Kamada Income Taxes 2012-2024 | KMDA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Kamada income taxes from 2012 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
Related Stocks
Company Name
Market
Cap
Amgen (AMGN)
$172.8B
Vertex Pharmaceuticals (VRTX)
$125.8B
Regeneron Pharmaceuticals (REGN)
$111.1B
Bristol Myers Squibb (BMY)
$108.2B
Gilead Sciences (GILD)
$108B
CSL (CSLLY)
$97B
GSK (GSK)
$81.3B
Alnylam Pharmaceuticals (ALNY)
$38.6B
Argenex SE (ARGX)
$32.3B
BioNTech SE (BNTX)
$28B
Biogen (BIIB)
$27.5B
Illumina (ILMN)
$22.9B
Moderna (MRNA)
$22.1B
BeiGene (BGNE)
$21.6B
Genmab (GMAB)
$15B
BioMarin Pharmaceutical (BMRN)
$13.3B
Insmed (INSM)
$13.2B
Vaxcyte (PCVX)
$13.2B
Exact Sciences (EXAS)
$13B
Incyte (INCY)
$12.7B
Sarepta Therapeutics (SRPT)
$12B
Bio-Techne Corp (TECH)
$11.4B
QIAGEN (QGEN)
$9.9B
Bio-Rad Laboratories (BIO.B)
$9.3B
Roivant Sciences (ROIV)
$8.9B
Revolution Medicines (RVMD)
$8.4B
Exelixis (EXEL)
$8.4B
Intra-Cellular Therapies (ITCI)
$8B
Legend Biotech (LEGN)
$8B
Ascendis Pharma (ASND)
$7.9B